The 33rd Florida International Medical Expo (FIME 2024) concluded at the Miami Beach Convention Center on June 21, 2024.
Held over three days, the exhibition brought together more than 1,300 exhibitors from 116 countries and regions. Participants explored medical technologies, industry trends and opportunities for international cooperation.
We presented our intraoperative nerve stimulation monitoring portfolio at the exhibition and connected with medical professionals, industry partners and media representatives from different markets.
Our intraoperative nerve stimulation monitoring system featured independent intellectual property rights and was developed for neurophysiological monitoring in surgical settings.
At the exhibition, we demonstrated the system’s monitoring capabilities and operating workflow. The demonstrations introduced the role of intraoperative neurophysiological monitoring in supporting the observation of neurophysiological signals during surgery.
The portfolio included our high-channel intraoperative monitoring system, which had received China’s first Category III registration for a high-channel intraoperative neuromonitoring system designed for orthopedic and neurosurgical procedures.
The exhibition also provided an opportunity to present our work in electrophysiology technology development, product research and medical-device manufacturing.
During FIME 2024, we held discussions with medical-device professionals and partners from around the world. The conversations covered intraoperative neuromonitoring, electrophysiology applications, market needs and potential cooperation models.
The exhibition enabled us to learn more about international market requirements and explore opportunities for cooperation in product access, regional development and medical-device services.
We also gained insight into evolving technology trends and practical needs across different healthcare markets.
We remained committed to translating technology development into professional medical-device solutions. Our participation in FIME 2024 provided an opportunity to present our intraoperative neuromonitoring portfolio to an international audience and exchange views on the development of medical technology.
The event strengthened our understanding of global market needs and reinforced our focus on independent research and development, product improvement and collaboration between industry and clinical practice.
FIME 2024 marked an important opportunity for us to present our capabilities, listen to market needs and connect with international partners.
We continued to focus on the development and application of intraoperative neuromonitoring technologies while strengthening global cooperation in electrophysiology. Through ongoing innovation and exchange, we advanced our vision of becoming a globally recognized electrophysiology service provider.
Copyright © NCC Medical Co., Ltd. - Privacy policy
EN